PhenX Logo
please waitPlease Wait...
PhenX Logo
My Toolkit
Log In

Review Measure

Essential Measures are only those items that are critical to the collection of the Measure or are necessary for the interpretation of results. Essential Measures are integral to the Measure. Without such information the data collected would be incomplete and/or misleading.
An additional PhenX Measure that the user may find helpful based on the selection of a particular PhenX Measure. Related PhenX Measures can include additional Measures that are needed to calculate a Derived Variable (e.g., Weight and Height are needed to calculate BMI), Measures that are commonly used in presentations and publications to present the value of the chosen Measures (e.g., Height and Weight by Race and Ethnicity), Measures that are conceptually related to the chosen Measure (e.g., Current Educational Attainment is conceptually related to Annual Family Income and Arm Span is conceptually related to Height), Measures that are physiologically and/or biologically related to the chosen Measure (e.g., Stroke and Heart Disease). Related PhenX Measures are suggestions only.
The Collections are an alternative to the research domains for browsing the PhenX Measures. Measures that are related by a specific topic are grouped together.

Browse » Collections » Mental Health Research » Early Psychosis Clinical Services Collection » Antipsychotic Medication Extrapyramidal Side Effects

Browse Previous MeasureBrowse Next Measure
Measure: Antipsychotic Medication Extrapyramidal Side Effects   #661600  About

Definition: A questionnaire and a patient examination tool to assess drug-induced extrapyramidal symptoms (slowness, stiffness, tremor, and rigidity).

Purpose: This measure is designed to assess the frequency and severity of antipsychotic drug-induced movement disorders (DIMD) including parkinsonism, dyskinesia, akathisia, and dystonia. DMID interferes with cognition and social rehabilitation and is similar to symptoms of psychosis and schizophrenia.



Early psychosis, psychosis, extrapyramidal symptom rating scale, ESRS, extrapyramidal features, drug-induced movement disorders, DIMD, drug-induced extrapyramidal symptoms, extrapyramidal side effects, EPSE

Measure Release Date: January 17, 2017

* Adding this measure to My Toolkit will add all protocols associated with this measure.

« Back To Measures List

Site maintained by RTI International Home   |   Browse   |   Search   |   My Toolkit   |   Feedback Release: July 2, 2018, Ver 23